The one industry to give a real thumbs-up to Trump was the Indian pharma industry. This is hardly surprising. Hilary Clinton was all for stringent norms to regulate the formulations and the generic drugs industry. The inquiry into price collusion could have become much bigger under Hilary Clinton. However, Trump being a businessman himself, understood the importance of government staying out of business. Also he is unlikely to scrap Obamacare but may tweak some changes to it. At the end of the day, he will open the US pharma market in a much bigger way for India.